What Teladoc Health (TDOC) Investors Need to Know Today

Shares of Health Care sector company Teladoc Health moved -0.4% today, and are now trading at a price of $20.43. The mid-cap stock's daily volume was 1,863,859 compared to its average volume of 5,054,034. The S&P 500 index returned a 1.0% performance.

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company is based in Purchase and has 4,816 full time employees. Its market capitalization is $3,382,329,344.

19 analysts are following Teladoc Health and have set target prices ranging from $16.0 to $34.0 per share. On average, they have given the company a rating of hold. At today's prices, TDOC is trading -8.22% away from its average analyst target price of $22.26 per share.

Over the last year, TDOC shares have gone down by -20.5%, which represents a difference of -44.1% when compared to the S&P 500. The stock's 52 week high is $34.36 per share and its 52 week low is $15.02. With average free cash flows of $97.91 Million that have been growing at an average rate of 90.8% over the last 6 years, Teladoc Health declining stock performance may not be reflective of the quality of its underlying business.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 285,488 16,255 269,233 55.8
2022 189,292 16,480 172,812 -6.82
2021 193,990 8,534 185,456 422.34
2020 -53,511 4,024 -57,535 -318.27
2019 29,869 3,510 26,359 397.14
2018 -4,860 4,011 -8,871
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS